Home
Dashboard
Curated content
Startups & Scaleups
SMEs & Corporates
Investors
Funding rounds
Accelerators
Universities
Governments & Non-profits
More organizations
Matching tool
Companies
Epitherapeutics
Save
Epitherapeutics
Developing novel innovative cancer drugs based on epigenetics.
Launch date
1987
Market cap
-
Enterprise valuation
$65m
(Public information from May 2015)
Foster City California (HQ)
http://epitherapeutics.dk
https://twitter.com/gileadsciences
biotechnology
biotechnology
Overview
Similar companies
Investments (2)
Analytics
Notes
Job openings
Innovations (0)
Epitherapeutics funding
Epitherapeutics investors
Edit
Date
Investors
Amount
Round
-
M Ventures
N/A
-
May 2015
Gilead Sciences
$65.0m
Valuation: $65.0m
Acquisition
Total Funding
-
Related Content
Recent News about Epitherapeutics
Edit
Investments by Epitherapeutics
Edit
AlloVir
exited
Tmunity Therapeutics
ACQUISITION by Kite Pharma Dec 2022